Click the link http://www.wix.com/conferencenet/mhd to visit Models of Human Diseases Conference website. To allow global participation and sharing since 2011 the International conference has been ongoing online.
Click the link to see the onsite 2010 conference http://conferencenet.wix.com/conference2010
Models of Human Diseases Conference is a forum for scientific exchange that gathers scientists from around the globe who use model organisms (rodents, yeast, Drosophila, C. elegans, zebra fish, chicken, Dictyostelium, snail, crayfish, etc.) or cells to understand various diseases.
It covers 18 major disease categories, as listed on the submit poster page. The key objective of this initiative is to generate better models of diseases that will lead to better understanding of the pathogenesis and treatment of disease and ultimately to advancement in basic science and more efficient testing of novel therapeutics.
This initiative is intended to facilitate international collaboration among scientists and clinicians from academic institutions, biotech and the pharmaceutical industry, clinical research organizations, and patient advocacy groups. It leads to the establishment of affiliations around the globe, that will allow for joint initiatives such as common applications for research grants and sharing of resources.
The conference was created by Dr. Rosalind Silverman and Dr. Lorelei Silverman from University of Toronto, Faculty of Medicine. The advisory team included Dr. Hamid Raziee, Dr. Ehsun Graham, Dr. Ruth Warre, Dr. Samina Nishat, Dr. Abbas Karbassian, Dr. Amar Al Ibrahim. They led team leaders that included high school students, undergraduate and graduate students, technicians, members of NGOs to organize the first ever online and onsite conference in Canada. The conference was supported by a grant from CIHR and numerous sponsors and was free for participants and for presenters to attend. Its aim was to speed up drug discovery and to facilitate easy access to pre-clinical models of drug testing, while increasing also awareness about diseases in 18 major diseases categories. Models of Human Diseases conference was supported by Disease Models and Mechanism Journal, one of the journals published by The Company of Biology.
With an impact factor of 4.94, DMM Journal is the most comprehensive journal addressing models of diseases and mechanisms. Many members and collaborators of our Models of Human Diseases Consortium published excellent papers in this journal such as one of the speakers from the Second Annual International Conference on Models of Human Diseases www.wix.com/conferencenet/mhd,
Dr. Cindy Morshead
Piccin D, Morshead CM. Potential and pitfalls of stem cell therapy in old age. Dis Model Mech. 2010 Jul-Aug;3(7-8):421-5. Epub 2010 May 26. PMID:20504968
or Dr. Edyta Marcon
Bahadorani S, Bahadorani P, Marcon E, Walker DW, Hilliker AJ.
A Drosophila model of Menkes disease reveals a role for DmATP7 in copper absorption and neurodevelopment. Dis Model Mech. 2010 Jan-Feb;3(1-2):84-91. Epub 2009 Dec 28. PMID: 20038716
Disease Models & Mechanisms (DMM) is a biomedical research journal committed to presenting highly significant research providing insight into disease mechanisms, diagnostics and treatment. The journal aspires to promote the development of new ideas, projects and collaborations among basic researchers, translational researchers, and clinicians. DMM also provides expert reviews and commentaries on key findings in the field, as well as clinical perspectives and challenges. As with other journals published by the Company of Biologists – Development, Journal of Cell Science and The Journal of Experimental Biology – DMM aims to provide strong support for our authors and great quality and breadth of published content to our readers. From 2011, all articles will be OPEN ACCESS: available immediately upon publication with unrestricted online access, published under a Creative Commons licence and deposited in PubMed Central for immediate release. 2011 Impact Factor: 4.937
Disease Models & Mechanisms will publish 6 issues in 2012.
- Models of Human diseases group was nominated for ScotiaBank Gamechanger